Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $51,854 | 1,107 | 62.8% |
| Consulting Fee | $19,318 | 8 | 23.4% |
| Travel and Lodging | $6,436 | 32 | 7.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,652 | 5 | 4.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,000 | 1 | 1.2% |
| Education | $214.30 | 22 | 0.3% |
| Gift | $59.40 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $26,739 | 193 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9,355 | 234 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $8,500 | 124 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $6,227 | 69 | $0 (2024) |
| Mannkind Corporation | $4,276 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $3,606 | 77 | $0 (2024) |
| Medtronic, Inc. | $2,829 | 36 | $0 (2024) |
| ABBVIE INC. | $2,361 | 36 | $0 (2024) |
| Lilly USA, LLC | $1,791 | 83 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,565 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,667 | 87 | Novo Nordisk Inc ($4,799) |
| 2023 | $23,480 | 155 | Novo Nordisk Inc ($17,409) |
| 2022 | $12,137 | 190 | Mannkind Corporation ($3,795) |
| 2021 | $10,721 | 195 | SANOFI-AVENTIS U.S. LLC ($2,646) |
| 2020 | $6,341 | 114 | SANOFI-AVENTIS U.S. LLC ($1,769) |
| 2019 | $7,234 | 168 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,443) |
| 2018 | $8,603 | 167 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,189) |
| 2017 | $4,350 | 100 | Boehringer Ingelheim Pharmaceuticals, Inc. ($760.75) |
All Payment Transactions
1,176 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.02 | General |
| Category: GI | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $110.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $117.46 | General |
| Category: Insulin Pump | ||||||
| 11/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $87.56 | General |
| 11/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $76.88 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Diabetes Care | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $96.15 | General |
| Category: VIROLOGY | ||||||
| 10/14/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $108.78 | General |
| Category: Insulin Pump | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $108.68 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Diabetes Care | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $93.76 | General |
| Category: Insulin Pump | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $88.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: HCV | ||||||
| 09/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Diabetes Care | ||||||
| 08/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $46.56 | General |
| 08/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 44 | 64 | $11,830 | $4,769 |
| 2022 | 1 | 32 | 57 | $11,400 | $4,420 |
| 2021 | 7 | 270 | 315 | $57,050 | $23,841 |
| 2020 | 12 | 323 | 363 | $55,370 | $20,177 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 26 | $5,350 | $2,419 | 45.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 38 | $6,480 | $2,350 | 36.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 57 | $11,400 | $4,420 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 57 | 57 | $12,255 | $7,363 | 60.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 91 | $12,740 | $4,799 | 37.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 63 | $12,600 | $4,756 | 37.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 55 | $11,210 | $3,849 | 34.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 12 | 12 | $3,540 | $2,007 | 56.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 20 | 20 | $3,600 | $783.63 | 21.8% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 16 | 17 | $1,105 | $284.57 | 25.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 84 | 95 | $13,245 | $4,044 | 30.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 30 | 46 | $9,200 | $3,884 | 42.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 52 | $10,660 | $3,590 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 30 | 30 | $6,450 | $3,316 | 51.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 30 | 32 | $5,760 | $1,906 | 33.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $2,860 | $1,009 | 35.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 14 | 14 | $1,960 | $826.22 | 42.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 18 | 18 | $1,710 | $609.34 | 35.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 20 | 20 | $880.00 | $324.28 | 36.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 13 | $1,105 | $307.55 | 27.8% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 16 | 17 | $1,085 | $236.14 | 21.8% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 13 | 13 | $455.00 | $124.52 | 27.4% |
About Dr. Maria Jones, MD
Dr. Maria Jones, MD is a Internal Medicine healthcare provider based in Allentown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962458240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Jones, MD has received a total of $82,533 in payments from pharmaceutical and medical device companies, with $9,667 received in 2024. These payments were reported across 1,176 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($51,854).
As a Medicare-enrolled provider, Jones has provided services to 669 Medicare beneficiaries, totaling 799 services with total Medicare billing of $53,207. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Allentown, PA
- Active Since 05/26/2006
- Last Updated 03/07/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962458240
Products in Payments
- JARDIANCE (Drug) $5,444
- FARXIGA (Drug) $4,327
- AFREZZA (Drug) $4,276
- XARELTO (Drug) $2,950
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $1,964
- Ozempic (Drug) $1,691
- STIOLTO RESPIMAT (Drug) $1,344
- XIFAXAN (Drug) $1,341
- NEXLIZET (Drug) $1,100
- Repatha (Biological) $1,011
- LINZESS (Drug) $879.66
- TRULICITY (Drug) $798.31
- Kerendia (Drug) $753.65
- UBRELVY (Drug) $691.66
- BRILINTA (Drug) $677.92
- LONHALA MAGNAIR (Drug) $668.64
- LOKELMA (Drug) $657.95
- INVOKANA (Drug) $656.09
- ELIQUIS (Drug) $613.24
- NURTEC ODT (Drug) $608.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Allentown
Shailendra Singh, M.d, M.D
Internal Medicine — Payments: $348,804
Dr. Sabahat Bokhari, M.d, M.D
Internal Medicine — Payments: $324,754
Dr. Orlando Penaloza, M.d, M.D
Internal Medicine — Payments: $135,198
Hiral Shah, Md, MD
Internal Medicine — Payments: $119,608
Elliot Sussman, Md, MD
Internal Medicine — Payments: $114,865
Michael Engels, M.d, M.D
Internal Medicine — Payments: $67,728